UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Monkeypox

The Lancet (British edition), 2023-01, Vol.401 (10370), p.60-74

2023

Volltextzugriff (PDF)

Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series

The Lancet (British edition), 2022-12, Vol.400 (10367), p.1953-1965

2022

Volltextzugriff (PDF)

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

Clinical infectious diseases, 2020-09, Vol.71 (6), p.1379-1389

2020

Volltextzugriff (PDF)

Ethnicity and outcomes in patients hospitalised with COVID-19 infection in East London: an observational cohort study

BMJ open, 2021-01, Vol.11 (1), p.e042140-e042140

2021

Volltextzugriff (PDF)

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

The New England journal of medicine, 2020-03, Vol.382 (12), p.1124-1135

2020

Volltextzugriff (PDF)

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

AIDS (London), 2014-05, Vol.28 (8), p.1193-1202

2014

Volltextzugriff (PDF)

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

The Lancet (British edition), 2013-03, Vol.381 (9868), p.735-743

2013

Volltextzugriff (PDF)

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Journal of acquired immune deficiency syndromes (1999), 2020-12, Vol.85 (4), p.498-506

2020

Volltextzugriff (PDF)

Neurocognitive function in HIV infected patients on antiretroviral therapy

PloS one, 2013-04, Vol.8 (4), p.e61949-e61949

2013

Volltextzugriff (PDF)

Cross-sectional survey of sexual health professionals’ experiences and perceptions of the 2022 mpox outbreak in the UK

BMJ open, 2024-01, Vol.14 (1), p.e080250

2024

Volltextzugriff (PDF)

Study protocol: the ILANA study – exploring optimal implementation strategies for long-acting antiretroviral therapy to ensure equity in clinical care and policy for women, racially minoritised people and older people living with HIV in the UK – a qualitative multiphase longitudinal study design

BMJ open, 2023-07, Vol.13 (7), p.e070666-e070666

2023

Volltextzugriff (PDF)

Brief Report: Durable Suppression and Low Rate of Virologic Failure 3 Years After Switch to Dolutegravir + Rilpivirine 2-Drug Regimen: 148-Week Results From the SWORD-1 and SWORD-2 Randomized Clinical Trials

Journal of acquired immune deficiency syndromes (1999), 2020-11, Vol.85 (3), p.325-330

2020

Volltextzugriff (PDF)

Rationale and design of the Self-TI Study protocol: a cross-sectional human papillomavirus self-testing pilot study among transgender adults in England

BMJ open, 2024-07, Vol.14 (7), p.e086099

2024

Volltextzugriff (PDF)

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

The Lancet (British edition), 2015-03, Vol.385 (9973), p.1098-1106

2015

Volltextzugriff (PDF)

Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults

Journal of acquired immune deficiency syndromes (1999), 2017-06, Vol.75 (2), p.226-231

2017

Volltextzugriff (PDF)

The under-representation of racially minoritised doctors in academic general practice training: a retrospective analysis

BJGP open, 2024-07, Vol.8 (2), p.BJGPO.2023.0136

2024

Volltextzugriff (PDF)

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

Journal of clinical oncology, 2012-11, Vol.30 (33), p.4111-4116

2012

Volltextzugriff (PDF)

Implementing long-acting injectable cabotegravir and rilpivirine in Africa

The Lancet infectious diseases, 2024-10, Vol.24 (10), p.1060-1061

2024

Volltextzugriff (PDF)

Brief Report: Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 Trials

Journal of acquired immune deficiency syndromes (1999), 2021-12, Vol.88 (4), p.393-398

2021

Volltextzugriff (PDF)

Hospitalization risk among patients with Mpox infection—a propensity score matched analysis

Therapeutic advances in infectious disease, 2023-01, Vol.10

2023

Volltextzugriff (PDF)

A phase IV randomised, open-label pilot study to evaluate switching from protease-inhibitor based regimen to Bictegravir/Emtricitabine/Tenofovir Alafenamide single tablet regimen in Integrase inhibitor-naïve, virologically suppressed HIV-1 infected adults harbouring drug resistance mutations (PIBIK study): study protocol for a randomised trial

BMC infectious diseases, 2020-07, Vol.20 (1), p.1-12, Article 524

2020

Volltextzugriff (PDF)

1 – 25 von 280

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(272)
Mit Volltextzugriff
(241)

Publikationsform

Artikel
(278)
Berichte
(2)

Sprache

Englisch
(279)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Monkeypox

Human monkeypox virus infection in women and non-binary individuals during the 2022 outbreaks: a global case series

Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials

Ethnicity and outcomes in patients hospitalised with COVID-19 infection in East London: an observational cohort study

Long-Acting Cabotegravir and Rilpivirine after Oral Induction for HIV-1 Infection

Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy

Mpox in people with past infection or a complete vaccination course: a global case series

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study

Neurocognitive function in HIV infected patients on antiretroviral therapy

Cross-sectional survey of sexual health professionals’ experiences and perceptions of the 2022 mpox outbreak in the UK

Study protocol: the ILANA study – exploring optimal implementation strategies for long-acting antiretroviral therapy to ensure equity in clinical care and policy for women, racially minoritised people and older people living with HIV in the UK – a qualitative multiphase longitudinal study design

Brief Report: Durable Suppression and Low Rate of Virologic Failure 3 Years After Switch to Dolutegravir + Rilpivirine 2-Drug Regimen: 148-Week Results From the SWORD-1 and SWORD-2 Randomized Clinical Trials

Rationale and design of the Self-TI Study protocol: a cross-sectional human papillomavirus self-testing pilot study among transgender adults in England

Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 study

Brief Report: Long-Term (96-Week) Efficacy and Safety After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in HIV-Infected, Virologically Suppressed Adults

The under-representation of racially minoritised doctors in academic general practice training: a retrospective analysis

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals

Efficacy and safety of grazoprevir (MK-5172) and elbasvir (MK-8742) in patients with hepatitis C virus and HIV co-infection (C-EDGE CO-INFECTION): a non-randomised, open-label trial

Implementing long-acting injectable cabotegravir and rilpivirine in Africa

Brief Report: Efficacy and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Females Living With HIV: An Integrated Analysis of 5 Trials

Hospitalization risk among patients with Mpox infection—a propensity score matched analysis

Suchergebnisse filtern